Pfizer faces several headwinds, including patent cliffs, regulatory risks, and a setback in obesity drug development. Click ...

U.S. lawmakers on Thursday asked Pfizer Inc for information on alleged comments by a former executive suggesting its research ...

The GOP-led House Judiciary Committee is investigating allegations that Pfizer delayed its COVID-19 vaccine testing until ...

Pfizer beats EPS estimates for the 12th quarter. Explore PFE's oncology success, cost-cutting impact, and why it's rated a ...

Albert Bourla said Pfizer is being "frugal" with investments because of the uncertainty surrounding tariffs.

From making her Europe’s vaccine saviour to becoming a skeleton in her closet: All the ebbs and flows in the love story ...

Like his Big Pharma peers, Pfizer (PFE) CEO Albert Bourla is waiting for the US government to finalize its decision on whether to place a 25% tariff on pharmaceutical imports. To be sure ...

The House Judiciary Committee revealed Thursday that Pfizer’s former Global Head of Vaccines Research and Development, Dr.

but Pfizer CEO Albert Bourla has said the timing had nothing to do with politics. In an interview with CNN Chief Medical Correspondent Sanjay Gupta in 2020, Bourla threw cold water on the idea ...